牛牛AI助理已提取核心訊息
On February 14, 2024, Caroline Litchfield, EVP & CFO of Merck & Co., Inc. [MRK], completed a sale of 38,291 shares of common stock at a price of $125.50 per share. The transaction resulted in a total market value of $4,805,520.50. Prior to this sale, Litchfield exercised options to acquire the same number of shares at $58.08 per share. Following these transactions, Litchfield's direct holdings in Merck & Co. amounted to 50,908.194 shares of common stock.
On February 14, 2024, Caroline Litchfield, EVP & CFO of Merck & Co., Inc. [MRK], completed a sale of 38,291 shares of common stock at a price of $125.50 per share. The transaction resulted in a total market value of $4,805,520.50. Prior to this sale, Litchfield exercised options to acquire the same number of shares at $58.08 per share. Following these transactions, Litchfield's direct holdings in Merck & Co. amounted to 50,908.194 shares of common stock.
2024年2月14日，默沙東公司 [MRK] 執行副總裁兼首席財務官卡羅琳·利奇菲爾德以每股125.50美元的價格完成了38,291股普通股的出售。該交易的總市值爲4,805,520.50美元。在此次出售之前，利奇菲爾德行使了期權，以每股58.08美元的價格收購了相同數量的股份。這些交易之後，利奇菲爾德在默沙東公司的直接持有量爲50,908.194股普通股。
2024年2月14日，默沙東公司 [MRK] 執行副總裁兼首席財務官卡羅琳·利奇菲爾德以每股125.50美元的價格完成了38,291股普通股的出售。該交易的總市值爲4,805,520.50美元。在此次出售之前，利奇菲爾德行使了期權，以每股58.08美元的價格收購了相同數量的股份。這些交易之後，利奇菲爾德在默沙東公司的直接持有量爲50,908.194股普通股。
有用
沒用